Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort

BACKGROUND: Currently, no biomarkers are able to differentiate lethal from relatively indolent prostate cancer (PCa) within high-risk diseases. Nonetheless, several molecules are under investigation. Amongst them, topoisomerase-II-alpha (TOPIIA), Ki67 and miR-221 showed promising results. Our aim wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Marra, Giancarlo, Oderda, Marco, Calleris, Giorgio, Marquis, Alessandro, Peretti, Federica, Zitella, Andrea, Moschini, Marco, Sanchez-Salas, Rafael, Karnes, Robert Jeffrey, Kneitz, Burkhard, Spahn, Martin, Pacchioni, Donatella, Gontero, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547160/
https://www.ncbi.nlm.nih.gov/pubmed/36217395
http://dx.doi.org/10.21037/tau-21-628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547160/
https://www.ncbi.nlm.nih.gov/pubmed/36217395
http://dx.doi.org/10.21037/tau-21-628

Ejemplares similares